Unites States Food News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2 
“gammaCore (nVNS) is the only treatment option, drug or device, that is currently available for the acute and preventive treatment of migraine in adolescents,” said Eric Liebler, Senior Vice President of Neurology at electroCore, Inc. “With their interest in technology and desire to avoid prescription drugs, gammaCore represents a unique treatment for adolescents with migraine. We would like to thank the Division of Neuromodulation and Physical Medicine Devices and their colleagues at the FDA for their efforts to review and clear the expanded label for gammaCore.
The label expansion was based on previously reported randomized controlled trials of gammaCore for the acute and preventive treatment of migraine, and was supported by a small study (n=9) in adolescents where 46.8% of all treated attacks were successfully resolved without the use of any acute rescue medication. ....

United States , University Of Cincinnati , Eric Liebler , Andrew Hershey , Core Inc , Drug Administration , University Of Cincinnati College Medicine , Neurology At Cincinnati Children Medical Center , Division Of Neuromodulation , European Union , Unites States Food , Endowed Chair , Cincinnati Children , Medical Center , Cincinnati College , Senior Vice President , Physical Medicine Devices , Cluster Headache , Trigeminal Autonomic Cephalalgias , Hemicrania Continua , Medication Overuse Headache , Nasdaq Ecor , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் ஸிந்ஸந்யாடீ , ஆண்ட்ரூ ஹெர்ஷே , கோர் இன்க் ,